COMMUNIQUÉS West-GlobeNewswire

Centivo Adds Two Industry Veterans to Leadership Team
20/10/2026
Longtime Health System Consultant Dr. Lisa Bielamowicz joins as Chief Health Officer Health Benefits Consultant and Sales Leader James Parr joins as Chief Commercial Officer BUFFALO, N.Y., Oct. 20, 2026 (GLOBE NEWSWIRE [...]
Femasys Partners with SandsRx Pharmacy to Support FemaSeed® Fertility Portfolio Launch to OB/GYNs
20/10/2026
First in a planned network of specialty pharmacy partnerships provides medication coordination and preferred pricing for OB/GYNs and their patients ATLANTA, Oct. 20, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY [...]
Inseer Appoints Eugene “Woody” Ritchey CEO to Lead Next Phase of Enterprise Growth
20/10/2026
Company introduces Enterprise Human Motion Intelligence strategy, expanding on its AI-powered human motion analysis to improve workplace safety, productivity and performance IOWA CITY, Iowa, Oct. 20, 2026 (GLOBE [...]
Creative Medical Technology Holdings Highlights 93% Patient Response Rate and 65% Reduction in Average Pain Scores in Ultrasome™ Knee Osteoarthritis Study
20/10/2026
International Scientific Presentation Underscores Encouraging Clinical Outcomes and Additional Biological Potency Findings Supporting Cell-Free Regenerative Platform PHOENIX, Oct. 20, 2026 (GLOBE NEWSWIRE) -- Creative [...]
MRI Patients Want to Keep Their Respirators On. ReadiMask Gives Technologists Independent MR Safe Documentation
20/10/2026
MED Institute's ASTM F2503-26 determination supports a strapless, adhesive-sealing respirator for MRI use, addressing an important safety question for patients and imaging professionals ReadiMask® worn by a patient [...]
Forget the Ugly Sweaters and Ugly Charts, NeOnc is Ready for Catalyst Season
20/10/2026
NeOnc’s November FDA Meeting and Abu Dhabi Treatment Developments Put Brain Cancer Research in the Spotlight DENVER, Oct. 20, 2026 (GLOBE NEWSWIRE) -- ( 247marketnews.com ) -- At an ugly-sweater party, the one with the [...]
Oncolytics Biotech® to Present REO 033 Trial in Progress Abstract at ESMO Showcasing Pelareorep’s Potential in Colorectal Cancer
20/10/2026
Study launched earlier this year is expected to confirm previous efficacy signal in 2L KRAS-mutant MSS colorectal cancer study that saw 17 months PFS vs. 6 months for the historical standard of care SAN DIEGO, Oct. 20, [...]
Five Years After Netflix’s ‘Sex, Love & Goop,’ Darshana Avila Announces ‘It’s My Pleasure’ Women’s Retreat
20/10/2026
The sexological bodyworker featured on the series says the conversation about women's sexual health has opened up since 2021, even as social media keeps shutting it down. Oakland, CA, Oct. 20, 2026 (GLOBE NEWSWIRE) -- [...]
As Autism and ADHD Diagnoses Surge, Love on the Autism Spectrum Offers Free Sessions for Long-Married Couples Who Never Had a Name for It
20/10/2026
Late-identified at 57 and with her partner more than 40 years, couples specialist Barbara "Blaze" Lazarony says the crisis isn't the diagnosis. It's the decades of marriage spent without one. Pacific Grove, CA, Oct. 20 [...]
Applied AI Company Baba Raises $40 Million Series A to Improve the Medicare Experience
20/10/2026
Round led by FirstMark Capital, with CVS Health Ventures and Valtruis joining returning investors General Catalyst, Genius Ventures and Ground Up Ventures Funding will expand Baba’s clinical care teams, advance its AI [...]
MyCardiologist Opens New Ambulatory Care Center in Miami Lakes, Expanding Access to Outpatient Cardiovascular Care
20/10/2026
MyCardiologist Ambulatory Care Center provides specialized cardiovascular procedures in an outpatient setting and strengthens MyCardiologist’s ability to care for patients throughout South Florida MIAMI LAKES, Fla., Oct [...]
ITM and Lumara Bio Announce Dose-Response Analysis for ¹⁷⁷Lu-edotreotide (ITM-11) and Data Supporting Early-Stage Pipeline at EANM 2026
20/10/2026
Dose-response analysis from Phase 3 COMPETE trial shows an association between higher absorbed doses of ¹⁷⁷Lu-edotreotide in tumors and improved clinical response in GEP-NETs Separate independent, investigator-led [...]
Correction: ITM and Lumara Bio Announce Dose-Response Analysis for ¹⁷⁷Lu-edotreotide (ITM-11) and Data Supporting Early-Stage Pipeline at EANM 2026
20/10/2026
Dose-response analysis from Phase 3 COMPETE trial shows an association between higher absorbed doses of ¹⁷⁷Lu-edotreotide in tumors and improved clinical response in GEP-NETs Separate independent, investigator-led [...]
Slate Medicines Strengthens Board of Directors with Appointment of Stephen K. Brannan, MD, and John D. Young
20/10/2026
RALEIGH, N.C., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Slate Medicines, Inc. (“Slate”), a clinical-stage biotechnology company committed to advancing innovative new therapies that may broaden the treatment paradigm and [...]
Odyssey Therapeutics Presents Completed Phase 2a OD-001 Induction Results Strengthening Clinical Proof of Concept at UEG Week 2026
20/10/2026
Correlation between clinical efficacy and changes in inflammatory biomarkers, mucosal transcriptomic signatures, and histologic disease activity strengthens the previously shown clinical proof of concept for OD-001 [...]
Aclarion Publishes CEO Shareholder Letter Highlighting Continued Scan Volume Growth and Advancing Clinical Program in Third Quarter 2026
20/10/2026
85% year-over-year scan volume growth in Q3 2026, contributing to 117% growth for the nine months ended September 30, 2026 European Spine Journal publishes peer-reviewed data supporting MRS as a potential viable [...]
PolarityBio Highlights Highest Scoring Abstract Award and Presentation of Phase 3 COVER DFUS II Trial Results at SAWC Fall 2026
20/10/2026
“Autologous Cutaneous Multicellular Units in Non-Healing Wagner 1 Diabetic Foot Ulcers: Results of the Phase 3 COVER DFUS II Trial” honored with top award in Clinical Research category Pivotal Phase 3 trial met primary [...]
Mammogen Names National Cancer Screening Leader, Dr. Rebecca Kaltman, to Lead Pivotal genTRU-breast™ Study
20/10/2026
Executive Director of the Inova Saville Cancer Screening and Prevention Center will lead KATELYN-ERIN, Mammogen’s large prospective study evaluating its blood-based RNA assay to support breast cancer detection NEWPORT [...]
Kane Biotech Signs Distribution Agreement with The Stevens Company
20/10/2026
Expands Kane Biotech’s commercial footprint and access to the revyve ® product line across Canada WINNIPEG, Manitoba, Oct. 20, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company”, “Kane” or “Kane [...]

Pages